Detalles de la búsqueda
1.
Long-term outcomes of high-risk HR-positive and HER2-negative early breast cancer patients from GEICAM adjuvant studies and El Álamo IV registry.
Breast Cancer Res Treat
; 201(2): 151-159, 2023 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-37338729
2.
Pain Behaviors Analyzed by Videorecording in Brain-Injured Patients Admitted to the Intensive Care Unit.
Pain Manag Nurs
; 24(2): 113-122, 2023 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-36057509
3.
Effectiveness of a healthcare-based mobile intervention on sedentary patterns, physical activity, mental well-being and clinical and productivity outcomes in office employees with type 2 diabetes: study protocol for a randomized controlled trial.
BMC Public Health
; 22(1): 1269, 2022 06 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-35768818
4.
Trajectories of alcohol consumption during life and the risk of developing breast cancer.
Br J Cancer
; 125(8): 1168-1176, 2021 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-34483338
5.
Fruit consumption and cardiometabolic risk in the PREDIMED-plus study: A cross-sectional analysis.
Nutr Metab Cardiovasc Dis
; 31(6): 1702-1713, 2021 06 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-33838995
6.
Efficacy of prompted voiding for reversing urinary incontinence in older adults hospitalized in a functional recovery unit: Study protocol.
J Adv Nurs
; 77(8): 3542-3552, 2021 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-34142726
7.
Psoriasis: From Pathogenesis to Pharmacological and Nano-Technological-Based Therapeutics.
Int J Mol Sci
; 22(9)2021 May 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-34067151
8.
A multivariable prognostic score to guide systemic therapy in early-stage HER2-positive breast cancer: a retrospective study with an external evaluation.
Lancet Oncol
; 21(11): 1455-1464, 2020 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33152285
9.
Ribociclib plus letrozole versus chemotherapy for postmenopausal women with hormone receptor-positive, HER2-negative, luminal B breast cancer (CORALLEEN): an open-label, multicentre, randomised, phase 2 trial.
Lancet Oncol
; 21(1): 33-43, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31838010
10.
Frequency and spectrum of PIK3CA somatic mutations in breast cancer.
Breast Cancer Res
; 22(1): 45, 2020 05 13.
Artículo
en Inglés
| MEDLINE | ID: mdl-32404150
11.
Care of older people with Cognitive Impairment or Dementia Hospitalized in Traumatology Units (CARExDEM): a quasi-experiment.
BMC Geriatr
; 20(1): 246, 2020 07 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-32677894
12.
Application of the Behavioural Indicators of Pain Scale in patients with traumatic brain injury.
J Adv Nurs
; 76(7): 1862-1870, 2020 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-32338391
13.
Efficacy of "optimal hydration" during labor: HYDRATA study protocol for a randomized clinical trial.
Res Nurs Health
; 43(1): 8-16, 2020 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-31793019
14.
Phase III evaluating the addition of fulvestrant (F) to anastrozole (A) as adjuvant therapy in postmenopausal women with hormone receptor-positive HER2-negative (HR+/HER2-) early breast cancer (EBC): results from the GEICAM/2006-10 study.
Breast Cancer Res Treat
; 177(1): 115-125, 2019 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-31152327
15.
Development and validation of a sexual relations satisfaction scale in patients with breast cancer - "SEXSAT-Q".
Health Qual Life Outcomes
; 17(1): 143, 2019 Aug 17.
Artículo
en Inglés
| MEDLINE | ID: mdl-31420041
16.
Selecting and quantifying low-value nursing care in clinical practice: A questionnaire survey.
J Clin Nurs
; 28(21-22): 4053-4061, 2019 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-31287603
17.
Changes in metabolic risk, insulin resistance, leptin and adiponectin following a lifestyle intervention in overweight and obese breast cancer survivors.
Eur J Cancer Care (Engl)
; 27(4): e12861, 2018 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-29869823
18.
HER2-enriched subtype as a predictor of pathological complete response following trastuzumab and lapatinib without chemotherapy in early-stage HER2-positive breast cancer (PAMELA): an open-label, single-group, multicentre, phase 2 trial.
Lancet Oncol
; 18(4): 545-554, 2017 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-28238593
19.
Neoadjuvant Therapy with Weekly Nanoparticle Albumin-Bound Paclitaxel for Luminal Early Breast Cancer Patients: Results from the NABRAX Study (GEICAM/2011-02), a Multicenter, Non-Randomized, Phase II Trial, with a Companion Biomarker Analysis.
Oncologist
; 22(11): 1301-1308, 2017 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-28701571
20.
Physical activity and breast cancer risk by pathological subtype.
Gynecol Oncol
; 144(3): 577-585, 2017 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-28057355